PARIS, France, September 12 /PRNewswire-FirstCall/ -- ExonHit Therapeutics S.A. (Alternext : ALEHT), a drug and diagnostic discovery company, announces today the availability of its new internet portal that will enable the biomedical community to order microarrays designed to study the expression of the entire human genome.
